We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$229B
AUM Growth
-$7.39B
Cap. Flow
+$1.73B
Cap. Flow %
0.76%
Top 10 Hldgs %
35.02%
Holding
11,057
New
1,520
Increased
3,775
Reduced
4,205
Closed
1,444

Sector Composition

Rank Sector Weight
1 Technology 2.23%
2 Consumer Discretionary 2.03%
3 Financials 1.67%
4 Communication Services 1.15%
5 Healthcare 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGF.A
8301
CALL
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$155K ﹤0.01%
20,900
+8,100
+63% +$77.5K
CARG icon
8302
CALL
CarGurus
CARG
$3.35B
$154K ﹤0.01%
10,900
-143,400
-93% -$2.91M
GNW icon
8303
PUT
Genworth Financial
GNW
$3.75B
$154K ﹤0.01%
44,000
+9,300
+27% +$37.5K
IONQ icon
8304
IonQ
IONQ
$15.9B
$154K ﹤0.01%
30,465
+11,468
+60% +$63.6K
OPRX icon
8305
CALL
OptimizeRx
OPRX
$129M
$154K ﹤0.01%
10,400
-19,200
-65% -$380K
CMBT
8306
CMB.TECH NV
CMBT
$4.67B
$154K ﹤0.01%
10,035
-426,173
-98% -$6.49M
CMRX
8307
DELISTED
Chimerix, Inc.
CMRX
$154K ﹤0.01%
+80,189
New +$180K
ZUO
8308
DELISTED
Zuora, Inc.
ZUO
$154K ﹤0.01%
20,898
-96,791
-82% -$835K
GPRO icon
8309
GoPro
GPRO
$121M
$153K ﹤0.01%
30,978
-168,382
-84% -$1M
TVRD
8310
Tvardi Therapeutics
TVRD
$22M
$153K ﹤0.01%
457
-316
-41% -$114K
BNRG icon
8311
Brenmiller Energy
BNRG
$1.02M
$152K ﹤0.01%
+24
New +$158K
PTRA
8312
PUT
DELISTED
Proterra Inc. Common Stock
PTRA
$152K ﹤0.01%
30,500
-12,400
-29% -$69.5K
GSRMU
8313
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
$152K ﹤0.01%
14,822
+522
+4% +$5.26K
PNTM.U
8314
DELISTED
Pontem Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
PNTM.U
$152K ﹤0.01%
15,317
-150
-1% -$1.49K
CHAA.U
8315
DELISTED
Catcha Investment Corp Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
CHAA.U
$152K ﹤0.01%
15,308
+1,116
+8% +$11K
KPTI icon
8316
PUT
Karyopharm Therapeutics
KPTI
$44.4M
$151K ﹤0.01%
1,840
-1,140
-38% -$85.2K
GTHX
8317
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$151K ﹤0.01%
12,100
-1,500
-11% -$17.1K
BTAI icon
8318
BioXcel Therapeutics
BTAI
$28.7M
$150K ﹤0.01%
+792
New +$184K
DAN icon
8319
PUT
Dana Inc
DAN
$3.21B
$150K ﹤0.01%
13,100
-29,200
-69% -$443K
LILA icon
8320
Liberty Latin America Class A
LILA
$1.67B
$150K ﹤0.01%
+35,589
New +$172K
MREO
8321
Mereo BioPharma
MREO
$43.5M
$150K ﹤0.01%
173,786
+151,762
+689% +$186K
PRG icon
8322
PUT
PROG Holdings
PRG
$1.68B
$150K ﹤0.01%
10,000
-2,800
-22% -$52.6K
UNIT
8323
Uniti Group
UNIT
$2.28B
$150K ﹤0.01%
21,530
-34,197
-61% -$318K
YELL
8324
DELISTED
Yellow Corporation Common Stock
YELL
$150K ﹤0.01%
29,557
-55,236
-65% -$303K
TGI
8325
DELISTED
Triumph Group
TGI
$149K ﹤0.01%
17,367
-20,657
-54% -$270K

Similar funds

Jane Street's Q3 2022 Portfolio in Review

As of Q3 2022, Jane Street held 11,057 positions worth $229B, down 3.1% from $236B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Jane Street's Q3 2022 filing shows 1,520 new, 3,775 increased, 4,205 reduced and 1,444 closed positions. Its largest new stake was iShares Gold Trust: 8,373,079 shares worth $264M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.05B.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jane Street's largest Q3 2022 buy was iShares Gold Trust: 8,373,079 shares worth $264M.
  • Jane Street added most to Invesco QQQ Trust in Q3 2022, an estimated $1.36B increase.
  • Jane Street's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.05B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2022, selling an estimated $187M.
  • Jane Street's ten largest holdings make up 35% of its $229B portfolio in Q3 2022.
  • Jane Street opened 1,520 new positions and closed 1,444 in Q3 2022.
  • Jane Street's portfolio value fell 3.1% quarter-over-quarter to $229B.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.